Diabetic ketoacidosis severity assessment and management calculator. Calculates anion gap, corrected sodium, osmolality, and provides insulin and fluid protocol guidance.
Diabetic Ketoacidosis (DKA) is a life-threatening complication of diabetes characterized by the triad of hyperglycemia (blood glucose >250 mg/dL), metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L), and ketonemia. It occurs when insulin deficiency forces the body to rely on fat metabolism for energy, producing ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone) that accumulate in the blood and cause severe acidosis.
This DKA Calculator assesses severity using the American Diabetes Association (ADA) classification system, calculates critical derived values including anion gap, corrected sodium for hyperglycemia, effective osmolality, and the delta/delta ratio, and provides evidence-based treatment protocol guidance for IV fluids, insulin dosing, and electrolyte replacement. DKA carries a mortality rate of 0.5–5% in developed countries, primarily from cerebral edema (in pediatric patients), hypokalemia-induced cardiac arrest, and delayed recognition.
Early and aggressive management with isotonic fluids, continuous insulin infusion, and meticulous potassium monitoring is the cornerstone of DKA treatment. This calculator automates the complex calculations that guide these interventions, helping clinicians make rapid, evidence-based decisions at the bedside — though it never replaces clinical judgment and real-time laboratory monitoring.
DKA management involves simultaneous calculations for fluid replacement, insulin dosing, electrolyte correction, and severity assessment — all time-critical. Manual calculation errors at the bedside can lead to insulin overdosing, hypokalemia, or inadequate correction. This calculator automates these computations while providing the clinical context needed for safe decision-making. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain.
Anion Gap = Na⁺ − Cl⁻ − HCO₃⁻ (normal 8–12). Corrected Na⁺ = Measured Na⁺ + 1.6 × (Glucose − 100) / 100. Effective Osmolality = 2 × Na⁺ + Glucose/18 + BUN/2.8. Delta/Delta Ratio = (AG − 12) / (24 − HCO₃⁻). Insulin bolus = 0.1 U/kg. Insulin drip = 0.1 U/kg/hr.
Result: Moderate DKA: AG = 22, Corrected Na = 137.6, Insulin drip 7 U/hr
Anion gap = 132 − 98 − 12 = 22 (elevated). Corrected Na = 132 + 1.6×(450−100)/100 = 137.6. pH 7.15 and bicarb 12 = moderate severity. Insulin: 0.1 × 70 = 7 units IV bolus then 7 U/hr drip. Initial fluid: 1–1.5 L NS in first hour.
DKA results from absolute or relative insulin deficiency combined with counter-regulatory hormone excess (glucagon, cortisol, catecholamines, growth hormone). Without insulin, glucose cannot enter cells, leading to hyperglycemia and osmotic diuresis. The body switches to fat metabolism, producing acetyl-CoA that overwhelms the Krebs cycle and is diverted to ketone body synthesis. These ketoacids (beta-hydroxybutyrate and acetoacetate) accumulate, causing the anion gap metabolic acidosis characteristic of DKA.
The average adult with DKA is depleted by 5–7 liters of water, 500–700 mEq sodium, 200–350 mEq potassium, 300–500 mEq chloride, and 200–400 mEq phosphate. These losses occur through osmotic diuresis driven by glycosuria and ketonuria. Aggressive but careful replacement is essential — too fast risks pulmonary edema and cerebral edema; too slow prolongs the metabolic crisis.
Cerebral edema occurs in 0.5–1% of pediatric DKA episodes and carries 25% mortality. Risk factors include severe acidosis, high BUN, younger age, and rapid osmolality changes during treatment. The exact mechanism is debated but likely involves vasogenic and cytotoxic edema from rapid fluid shifts. Early signs include headache, altered consciousness, and bradycardia. Treatment is immediate mannitol or hypertonic saline.
DKA is diagnosed when blood glucose >250 mg/dL, arterial pH <7.3, serum bicarbonate <18 mEq/L, anion gap >10, and serum or urine ketones are positive. All criteria should be present for a definitive diagnosis.
Despite often appearing normal or elevated on initial labs, total body potassium is severely depleted in DKA due to urinary losses. Insulin drives potassium into cells, potentially causing fatal hypokalemia. If K⁺ <3.3 mEq/L, insulin must be held until potassium is replaced.
The ADA recommends NaHCO₃ only when pH <6.9. At pH 6.9–7.0, it is considered on a case-by-case basis. Above pH 7.0, bicarbonate has not shown benefit and may cause paradoxical CNS acidosis and hypokalemia.
Hyperglycemia draws water from cells into the blood, diluting sodium. The corrected sodium formula (add 1.6 mEq/L per 100 mg/dL glucose above 100) reveals the true sodium status. A corrected sodium >145 suggests significant free water deficit.
DKA is resolved when glucose <200 mg/dL, bicarbonate ≥15 mEq/L, pH >7.3, and anion gap ≤12 mEq/L. The patient should also be tolerating oral intake. Overlap subcutaneous insulin 1–2 hours before stopping the insulin drip to prevent rebound ketosis.
The delta/delta ratio compares the rise in anion gap to the fall in bicarbonate. A ratio of 1–2 suggests pure anion gap metabolic acidosis. Ratio <1 suggests a concurrent non-anion gap acidosis. Ratio >2 suggests a concurrent metabolic alkalosis (e.g., from vomiting).